• Home
  • NEW DAY MEDICINE
  • 11 (49) 2022
  • 63 -11 (49) 2022 — N.Z. Yuldasheva., F.I. Shukurov, — A NEW APPROACH IN THE TREATMENT OF MENSTRUAL CYCLE DISTURBANCES IN WOMEN WITH COVID-19

63 -11 (49) 2022 — N.Z. Yuldasheva., F.I. Shukurov, — A NEW APPROACH IN THE TREATMENT OF MENSTRUAL CYCLE DISTURBANCES IN WOMEN WITH COVID-19

A NEW APPROACH IN THE TREATMENT OF MENSTRUAL CYCLE DISTURBANCES IN WOMEN WITH COVID-19

N.Z. Yuldasheva. Tashkent Medical Academy, Uzbekistan

F.I. Shukurov, Tashkent Medical Academy, Uzbekistan

G.M.Nigmatova Tashkent Medical Academy, Uzbekistan

Resume

Purpose Will evaluate the efficacy of inositol and 100 mcg folic acid dietary supplement in the treatment of menstrual irregularities in women with COVID-19.

Materials and methods. The study included 60 women aged 18 to 36 years with menstrual dysfunction due to COVID-9. Of these, 20 women were with oligomenorrhea and 20 with opsomenorrhea. Menstrual dysfunction in patients was characterized by oligomenorrhea in 33.3% and opsomenorrhea in 33.3% of women. For the correction of menstrual disorders, we first used a dietary supplement containing 1000 mg of inositol and 100 micrograms of folic acid. All patients underwent a comprehensive clinical, laboratory and instrumental study.

Result: After 3 months of corrective therapy with the use of a dietary supplement containing 1000 mg of inositol and 100 μg of folic acid, the menstrual cycle returned to normal in 84.5% of patients, positive dynamics of folliculogenesis and hormone levels in blood plasma were noted. Ovulation was registered in 85% of women.

Conclusion. The use of a dietary supplement containing 1000 mg of inositol and 100 μg of folic acid in the treatment of menstrual disorders in women against the background of COVID-19 improves the quality of life by 2.4 times and leads to the normalization of the menstrual cycle in 84.5%, ovulation – in 85 % of women.

Key words: menstrual cycle, oligomenorrhea, opsomenorrhea, dietary supplements, inositol and folic acid.

First page

344

Last page

348

For citation: N.Z. Yuldasheva., F.I. Shukurov, G.M.Nigmatova – A NEW APPROACH IN THE TREATMENT OF MENSTRUAL CYCLE DISTURBANCES IN WOMEN WITH COVID-19 //New Day in Medicine 11(49)2022 344-348 https://clck.ru/32ooXA

LIST OF REFERENCES:

  1. Адамян Л.В., Азнаурова Я.Б., Филиппов О.С. COVID-19 и женское здорове (обзор литературы) // Проблемы репродукции. 2020.Т.26, №2. С.6–17.
  2. Андрогенная алопеция и  коронавирусная  инфекция / О.О. Мелниченко,  Л.Р.  Сакания, А.Л.  Пирузян, И.М.  Корсунская // Consilium medicum. – 2021. – Т. 23, № 8. – С. 617-620.
  3. Бавыкин А.С. Клеточный и молекулярный уровен стратегии CОВИД-19 по индуксии  иммунодефисита.  Возможные терапевтические решения / А. С. Бавыкин // Журнал микробиологии, эпидемиологии и иммунобиологии. – 2021. – № 4. – С. 450-467.
  4. Временное клиническое руководство по ведению CОВИД-19 при беременности, родах и послеродовом периоде // Ташкент-2020г. С.-31.
  5. Шукуров Ф.И., Аюпова Ф.М. Новое в восстановлении фертилности у женщин после эндохирургического лечения синдрома поликистозных яичников // Биология ва тиббиёт муаммолари, 2018, 4,1 (105) 175-176.
  6. David S. Hui. Yepidemic and Yemerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle Yeast Respiratory Syndrome) // Clin. Chest. Med. – 2017. – Vol. 38. – №1. – P. 71–86.
  7. Cai Q., Huang D., Ou P., Yu H., Zhu Zh., Xia Zh., Su Y., Ma Zh., Zhang  .Y., Li Zh., He Q.,  Liu L.,  Fu Y.,  Chen J. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. MedRxiv. 2020.
  8. Chan J.F., Kok K.H., Zhu Z., Chu H., To K.K., Yuan S., Yuen K. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan / Yemerg. Mi Yu C., Liu Q., Deyin G. Yemerging coronaviruses: genome structure, replication, and pathogenesis // J. Med. Virol. – 2020. – Vol. 92. – №4. – P. 418–423.
  9. S’hen Ch., Wang Zh., Zhao F., Yang Y., Li J., Yuan J., Wang F., Li D., Yang M., Xing L., Wei J., Xiao H., Yang Y., Qu J., Qing L., Chen L., Xu Zh., Peng L., Li Y., Zheng H., Chen F., Huang K., Jiang Y., Liu D., Zhang Zh., Liu Y., Liu L. Treatment of 5 critically ill patients with COVID-19 with convalescent  plasma.  // JAMA.  2020;  323  (16):  1582-1589. 
  10. Zha L., Li S’h., Pan L., Tefsen B., Li Y., French N., Chen L., Yang G., Villanueva Ye.V. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID‐19). // Medical Journal of Australia. 2020; 212 (9): 416-420.

file

download